A multicenter phase III study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies
Participants
number |
logo |
legal name |
short name |
country |
website |
1 |
 |
Charité – Universitätsmedizin Berlin | Charité | Germany |  |
2 |
 |
Paracelsus Medizinische Privatuniversität Salzburg Privatstiftung | PMU | Austria | |
3 |
 |
Asklepios Kliniken Hamburg Gmbh | Asklepios | Germany | |
4 |
 |
Universitäts GefäßCentrum und Medizinische Klinik III Bereich Angiologie Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden | UGC Dresden | Germany | |
5 |
 |
Pluristem Therapeutics Ltd | Pluristem | Israel | |
6 |
 |
ICON Clinical Research | ICON | Ireland | |
7 |
 |
Genome Identification Diagnostics GmbH | GenID | Germany | |
8 |
 |
ALTA Ricerca e Sviluppo in Biotecnologie S.r.l.u. Terminated |
ALTA | Italy | |
9 |
 |
Innovation Acta S.r.l. | INN-ACTA | Italy | |